Type 1 Diabetes Trial, Recruiting (NCT07125365)

Type 1 Diabetes Trial, Recruiting NCT07125365 Sponsor: University of Oxford Condition: Type 1 Diabetes

Printed from Voxsanity (voxsanity.com.au) — NCT07125365 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Type 1 Diabetes

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People aged between 6 months and 70 years old (male or female)
People who have tested positive for at least one specific antibody linked to type 1 diabetes (insulin, GAD, IA2, or ZnT8), with that result confirmed by a reference laboratory
People aged 16 or older who are willing and able to give their own consent to take part, or for children under 16, a parent or guardian who is able to give consent on their behalf (with the child's agreement where suitable)
People who are currently living in the UK
For one specific part of the trial (ADDRESS-2 participants only): people who previously took part in a blood draw as part of the ADDRESS-2 study
For a separate interview part of the trial: people who have been living with a positive antibody result for at least 6 months, or parents and guardians of a child who has been in that situation for at least 6 months

Who may not be able to join:

People who currently need insulin injections under the skin to manage their condition

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 15 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Rachel Besser, University of Oxford

Phone: +44(0)7765 932065

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07125365

Sponsor: University of Oxford

Phase: Not Applicable

Status: Recruiting

Condition: Type 1 Diabetes

Trial contact: +44(0)7765 932065

More information: https://clinicaltrials.gov/study/NCT07125365

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People aged between 6 months and 70 years old (male or female)
People who have tested positive for at least one specific antibody linked to type 1 diabetes (insulin, GAD, IA2, or ZnT8), with that result confirmed by a reference laboratory
People aged 16 or older who are willing and able to give their own consent to take part, or for children under 16, a parent or guardian who is able to give consent on their behalf (with the child's agreement where suitable)
People who are currently living in the UK
For one specific part of the trial (ADDRESS-2 participants only): people who previously took part in a blood draw as part of the ADDRESS-2 study
For a separate interview part of the trial: people who have been living with a positive antibody result for at least 6 months, or parents and guardians of a child who has been in that situation for at least 6 months

Who may not be able to join:

People who currently need insulin injections under the skin to manage their condition

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 15 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of Oxford

Registry

ClinicalTrials.gov

Start date

11 July 2025

Est. completion

31 May 2027

Where this trial is recruiting

🇬🇧 United Kingdom

Primary endpoints

Number of individuals enrolled on the registry

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov